Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
50.75
+4.17 (8.95%)
At close: Feb 6, 2026, 4:00 PM EST
51.74
+0.99 (1.95%)
After-hours: Feb 6, 2026, 4:03 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $2.19 billion as of February 6, 2026. Its market cap has increased by 227.07% in one year.
Market Cap
2.19B
Enterprise Value
1.64B
1-Year Change
227.07%
Ranking
Category
Stock Price
$50.75
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $2.19B, an increase of 1,245.79%. That is a compound annual growth rate of 195.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 2.01B | 13.95% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 2.22B |
| Mesoblast | 2.15B |
| Soleno Therapeutics | 2.13B |
| Maze Therapeutics | 2.11B |
| Harmony Biosciences Holdings | 2.10B |
| Olema Pharmaceuticals | 1.97B |
| Nuvation Bio | 1.93B |
| Ocular Therapeutix | 1.90B |